Sage Journals: Discover world-class research

Retricted access

Editorial

First published 2017-06

Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial

Aus Alzaid

Diabetes Technology & Therapeutics

Open access

Research article

First published 2020-7

Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey

Nathan D Wong, Wenjun Fan, Jonathan Pak

Diabetes & Vascular Disease Research

Open access

Brief report

First published 2020-11

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME ®

Gisle Langslet, Bernard Zinman, Christoph Wanner [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2010-11

Further studies into the feasibility of using aqueous alum solutions in the destruction of VX

Daniel J. Williams, William R. Creasy, Roderick A. Fry [...]

Main Group Chemistry

Retricted access

Research article

First published 2012-7

Being an Ally

Helen A. Neville, Michelle P. Flores, Milo L. Dodson

The Counseling Psychologist

Retricted access

Research article

First published 2009-6

Raman Microspectroscopy as a Valuable Additional Method to X-Ray Diffraction and Electron Microscope/Microprobe Analysis in the Study of Iron Arsenates in Environmental Samples

Michal Filippi, Vladimír Machovič, Petr Drahota [...]

Applied Spectroscopy

Retricted access

Research article

First published 2025-1

Investigating the impact of empagliflozin on the retina of diabetic mice

Juan Chen, Shenghui Zhang, Yao You [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2021-03

Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress

Panagiota Efstathia Nikolaou, Panagiotis Efentakis, Fairouz Abu Qourah [...]

Antioxidants & Redox Signaling

Retricted access

Research article

First published 2026-1

Empagliflozin Attenuates Diabetic Cardiomyopathy via Inhibiting Cardiomyocyte Ferroptosis Through the USP7/NRF2 Signaling Pathway

Min Cui, Junwei Zhang, Ziwei Wang [...]

Antioxidants & Redox Signaling

Free access

Research article

First published 2018-7

Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat

Firas Younis, Jonathan Leor, Zaid Abassi [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Search results